IO Biotech Inc (IOBT)
Official siteBIOTECHNOLOGY
Last updated: Apr 07, 2026 at 5:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 81.8% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 23.8, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about IOBT
News
No news available
Company news will appear here when available
IO Biotech Competitors
Peers by sector and size for IO Biotech (IOBT) include Healthcare Triangle, Neurosense Therapeutics and Vivos Therapeutics.
Sector: Healthcare
IOBT Bull Case vs Bear Case
Bear case
- IOBT beat EPS estimates in 37.5% of its last 8 reported quarters.
IOBT Earnings: Beat Rate
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -5.6%
Updated Mar 4, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About IOBT
Does IOBT pay dividends?
IO Biotech Inc (IOBT) does not currently pay a regular dividend.
IOBT pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.